- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroendocrine Tumor in New Zealand
Total 3193 results
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States, Australia, Canada
-
Novartis PharmaceuticalsCompletedCarcinoid Tumor | Malignant Carcinoid SyndromeFrance, Spain, Netherlands, United States, Canada, Sweden, Italy, Australia, Germany, Greece, Belgium, Czech Republic, Slovakia, Finland, United Kingdom
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Askin TumorUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; NYU Langone HealthCompletedSkin Cancer | Metastatic Melanoma | NeoplasmUnited States
-
Rockefeller UniversityCompletedMelanoma | Neoplasm MetastasisUnited States
-
StemcentrxTerminatedSmall Cell Lung CancerUnited States
-
National Cancer Institute (NCI)WithdrawnStage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF Positive Metastatic MelanomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
Genta IncorporatedCompletedDacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaMelanoma (Skin)United States
-
Miltenyi Biomedicine GmbHDLR German Aerospace CenterRecruiting
-
GlaxoSmithKlineUnknownMelanoma (Skin)United States
-
Idera Pharmaceuticals, Inc.CompletedMelanoma | Refractory Solid TumorsUnited States, Israel
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
AmgenCompletedSarcoma | Lymphoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors | Metastatic Cancer | Solid Tumors | Carcinoid | Locally AdvancedUnited States, Spain, Poland
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedGastric Cancer | Colorectal Cancer | Small Intestine Cancer | Ovarian Cancer | Peritoneal Cavity Cancer | Gastrointestinal Stromal Tumor | Gastrointestinal Carcinoid TumorUnited States
-
AmgenCompletedMelanomaUnited States, France, Germany
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingStage III/IV MelanomaUnited States, Australia, Canada, Italy, Switzerland
-
Ruhr University of BochumCompleted
-
PfizerActive, not recruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
SkylineDxRecruitingMelanomaUnited States
-
Genentech, Inc.Terminated
-
Molecular Insight Pharmaceuticals, Inc.UnknownPheochromocytoma | ParagangliomaUnited States
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
Provectus PharmaceuticalsCompleted
-
Hoffmann-La RocheRecruitingSmall Cell Lung Cancer | Neuroendocrine CarcinomaUnited States, Japan, Denmark, Spain, Poland
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
Eucure (Beijing) Biopharma Co., LtdActive, not recruitingMelanoma | Pancreatic Ductal AdenocarcinomaUnited States, Australia
-
Synta Pharmaceuticals Corp.TerminatedMelanomaUnited States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Melanoma Stage IIIUnited States
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedGastric Cancer | Pancreatic Cancer | Small Intestine Cancer | Liver Cancer | Extrahepatic Bile Duct Cancer | Gastrointestinal Carcinoid TumorUnited States
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Memorial Sloan Kettering Cancer CenterCompletedUveal MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Bristol-Myers SquibbMedarexCompletedAdvanced MelanomaUnited States